InvestorsHub Logo
Followers 163
Posts 3095
Boards Moderated 0
Alias Born 11/03/2014

Re: None

Saturday, 11/26/2022 11:39:54 PM

Saturday, November 26, 2022 11:39:54 PM

Post# of 700474
I would like an opinion on this presentation that Dr. Linda Liau gave in May 2021:



Beginning around the 46:45 minute mark, It sounds to me like Dr. Liau is saying that the Spore Project clinical trial that combines:

DCVax-L + PD-1 inhibitor + CSF-1 Receptor inhibitor

Dr. Liau seems to say that Bristol Myers Squibb (BMS) is the collaborator on this Spore Project clinical trial. If that is the case, then I would expect that BMS is providing the PD-1 inhibitor (Opdivo aka nivolumab) and the CSF-1 receptor inhibitor for this trial. Does everyone agree with that?
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News